SPIA
RCUS icon

Steward Partners Investment Advisory’s Arcus Biosciences RCUS Stock Holding History

Steward Partners Investment Advisory’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,000
Closed -$30.5K – 3832
2024
Q2 		$30.5K Hold
2,000
– – ﹤0.01% 2330
2024
Q1 		$37.8K Buy
+2,000
New +$34.6K ﹤0.01% 2240
2018
Q2 		– Sell
-200
Closed -$3K – 2529
2018
Q1 		$3K Buy
+200
New +$3.33K ﹤0.01% 1934

Other funds holding RCUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Steward Partners Investment Advisory's RCUS Position: Q3 2024 in Review

Steward Partners Investment Advisory sold out of Arcus Biosciences (RCUS) in Q3 2024, closing a stake of 2,000 shares — an estimated $30.5K sold.

Steward Partners Investment Advisory first reported a position in RCUS in Q1 2018 and held it in 3 quarters. The position peaked at $37.8K in Q1 2024. 187 funds tracked by Wall St. Rank hold RCUS as of Q3 2024.

  • Steward Partners Investment Advisory reported no remaining Arcus Biosciences position as of Q3 2024 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 2,000 Arcus Biosciences shares in Q3 2024, an estimated $30.5K.
  • Steward Partners Investment Advisory first reported a position in Arcus Biosciences in Q1 2018 and held it in 3 quarters.
  • Steward Partners Investment Advisory's Arcus Biosciences position peaked at $37.8K in Q1 2024.
  • 187 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2024.

Based on Steward Partners Investment Advisory's 13F filing for Q3 2024, filed 14 Nov 2024.